Alexandra Maria Ackerman, NP

Alexandra Ackerman practices at Piedmont Physicians at Inman Park in Atlanta, Georgia.

Alexandra Ackerman's NPI, 1669100418, was assigned on August 10, 2022. Alexandra Ackerman holds Georgia license RN283458.

Alexandra Ackerman's primary practice is Piedmont Physicians at Inman Park, at 3020 Paces Mill SE Rd, Atlanta, GA 30339 in Cobb County. The practice phone is (404) 658-9840.

Alexandra Ackerman's primary practice is Piedmont Physicians at Inman Park in Atlanta, Georgia. Alexandra Ackerman is also affiliated with Piedmont Atlanta. The medical group on file is Piedmont Physicians at Inman Park. Dmand AI also links Alexandra Ackerman to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexandra Ackerman practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Alexandra Ackerman's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Alexandra Ackerman is licensed in Georgia.

CMS counts 42 Medicare patients who saw Alexandra Ackerman in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexandra Ackerman's median patient age at 69, with 74% women.

In 2024, Alexandra Ackerman wrote 325 Medicare Part D claims for 75 patients. 74% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Alexandra Ackerman for performance year 2024, reported as part of a group. Alexandra Ackerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexandra Ackerman as offering telehealth.

CMS Open Payments shows 12 general payments to Alexandra Ackerman from 10 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $56.